首页 >
法规速递
-
Page: Questions and answers on post approval change management protocols - Scientific guideline-2025/12/11
2025-12-12查看详情 > -
Document: Draft guideline for the evaluation of efficacy of ectoparasiticides - general requirements-2026/1/23
2026-01-26查看详情 > -
Page: Fees for veterinary medicines-2026/3/2
2026-03-03查看详情 > -
国家药监局综合司公开征求《消费品使用说明第3部分：化妆品通用标签（征求意见稿）》等2项强制性国家标准意见-2026/3/30
2026-03-31查看详情 > -
Page: Development and manufacture of synthetic peptides - Scientific guideline-2026/5/12
2026-05-13查看详情 > -
S1B(R1) Addendum to S1B Testing for Carcinogenicity of Pharmaceuticals (Final)-2022/11/2
2022-11-30查看详情 > -
Draft Guidance: Pediatric Drug Development: Regulatory Considerations — Complying With the Pediatric Research Equity Act and Qualifying for Pediatric Exclusivity Under the Best Pharmaceuticals for Children Act-2023/5/17
2023-05-18查看详情 > -
国家药监局关于连花清咳片等3种处方药转换为非处方药的公告（2023年第145号）-2023/11/22
2023-11-23查看详情 > -
国家药监局关于同意成都市药品检验研究院作为锝标记及正电子类放射性药品检验机构的通告（2025年第5号）-2025/1/15
2025-01-17查看详情 > -
Page: Demonstration of efficacy for veterinary medicinal products containing antimicrobial substances - Scientific guideline-2025/2/21
2025-02-24查看详情 >
